組織診断薬の市場規模は、2023年に54億ドルと評価されました。この市場は、2024年の61億ドルから2032年までに148億ドルに成長し、予測期間(2024年から2032年)の間に13.50%のCAGRを示すと予測されます。組織診断市場は、乳がんや肺がんを含むさまざまな種類のがんの発生率の上昇など、重要な市場推進要因により、予測期間を通じて成長する予想されます。
								
						目次
						
	TABLE OF CONTENTS
	1. EXECUTIVE SUMMARY
	2. MARKET INTRODUCTION
	
	2.1. Definition
	2.2. Scope of the Study
	2.2.1. Research Objective
	2.2.2. Assumptions
	2.2.3. Limitations
	3. RESEARCH METHODOLOGY
	
	3.1. Overview
	3.2. Data Mining
	3.3. Secondary Research
	3.4. Primary Research
	3.4.1. Primary Interviews and Information Gathering Process
	3.4.2. Breakdown of Primary Respondents
	3.5. Forecasting Model
	3.6. Market Size Estimation
	3.6.1. Bottom-Up Approach
	3.6.2. Top-Down Approach
	3.7. Data Triangulation
	3.8. Validation
	4. MARKET DYNAMICS
	
	4.1. Overview
	4.2. Drivers
	4.3. Restraints
	4.4. Opportunities
	5. MARKET FACTOR ANALYSIS
	
	5.1. Value Chain Analysis
	5.2. Porter’s Five Forces Analysis
	5.2.1. Bargaining Power of Suppliers
	5.2.2. Bargaining Power of Buyers
	5.2.3. Threat of New Entrants
	5.2.4. Threat of Substitutes
	5.2.5. Intensity of Rivalry
	5.3. COVID-19 Impact Analysis
	5.3.1. Market Impact Analysis
	5.3.2. Regional Impact
	5.3.3. Opportunity and Threat Analysis
	6. GLOBAL TISSUE DIAGNOSTICS MARKET, BY PRODUCT
	
	6.1. Overview
	6.2. Instruments
	6.3. Reagents & Consumables
	7. GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY
	
	7.1. Overview
	7.2. Immunohistochemistry
	7.3. In-situ Hybridization
	7.4. Digital Pathology and Workflow Management
	7.5. Other Technologies
	8. GLOBAL TISSUE DIAGNOSTICS MARKET, BY APPLICATION
	
	8.1. Overview
	8.2. Breast Cancer
	8.3. Prostate Cancer
	8.4. Gastric Cancer
	8.5. Other Cancers
	9. GLOBAL TISSUE DIAGNOSTICS MARKET, BY REGION
	
	9.1. Overview
	9.1. North America
	9.1.1. US
	9.1.2. Canada
	9.2. Europe
	9.2.1. Germany
	9.2.2. France
	9.2.3. UK
	9.2.4. Italy
	9.2.5. Spain
	9.2.6. Rest of Europe
	9.3. Asia-Pacific
	9.3.1. China
	9.3.2. India
	9.3.3. Japan
	9.3.4. South Korea
	9.3.5. Australia
	9.3.6. Rest of Asia-Pacific
	9.4. Rest of the World
	9.4.1. Middle East
	9.4.2. Africa
	9.4.3. Latin America
	10. COMPETITIVE LANDSCAPE
	
	10.1. Overview
	10.2. Competitive Analysis
	10.3. Market Share Analysis
	10.4. Major Growth Strategy in the Global Tissue Diagnostics Market,
	10.5. Competitive Benchmarking
	10.6. Leading Players in Terms of Number of Developments in the Global Tissue Diagnostics Market,
	10.7. Key developments and Growth Strategies
	10.7.1. New Product Launch/Service Deployment
	10.7.2. Merger & Acquisitions
	10.7.3. Joint Ventures
	10.8. Major Players Financial Matrix
	10.8.1. Sales & Operating Income, 2023
	10.8.2. Major Players R&D Expenditure. 2023
	11. COMPANY PROFILES
	
	11.1. Abbott Laboratories
	11.1.1. Company Overview
	11.1.2. Financial Overview
	11.1.3. Products Offered
	11.1.4. Key Developments
	11.1.5. SWOT Analysis
	11.1.6. Key Strategies
	11.2. BioGenex Laboratories
	11.2.1. Company Overview
	11.2.2. Financial Overview
	11.2.3. Products Offered
	11.2.4. Key Developments
	11.2.5. SWOT Analysis
	11.2.6. Key Strategies
	11.3. Agilent Technologies Inc.
	11.3.1. Company Overview
	11.3.2. Financial Overview
	11.3.3. Products Offered
	11.3.4. Key Developments
	11.3.5. SWOT Analysis
	11.3.6. Key Strategies
	11.4. ILLUMINA Inc.
	11.4.1. Company Overview
	11.4.2. Financial Overview
	11.4.3. Products Offered
	11.4.4. Key Developments
	11.4.5. SWOT Analysis
	11.4.6. Key Strategies
	11.5. Merck KGa
	11.5.1. Company Overview
	11.5.2. Financial Overview
	11.5.3. Products Offered
	11.5.4. Key Developments
	11.5.5. SWOT Analysis
	11.5.6. Key Strategies
	11.6. Danaher Corporation
	11.6.1. Company Overview
	11.6.2. Financial Overview
	11.6.3. Products Offered
	11.6.4. Key Developments
	11.6.5. SWOT Analysis
	11.6.6. Key Strategies
	11.7. F. Hoffmann-La Roche Ltd
	11.7.1. Company Overview
	11.7.2. Financial Overview
	11.7.3. Products Offered
	11.7.4. Key Developments
	11.7.5. SWOT Analysis
	11.7.6. Key Strategies
	11.8. Qiagen NV
	11.8.1. Company Overview
	11.8.2. Financial Overview
	11.8.3. Products Offered
	11.8.4. Key Developments
	11.8.5. SWOT Analysis
	11.8.6. Key Strategies
	11.9. Thermo Fisher Scientific Inc.
	11.9.1. Company Overview
	11.9.2. Financial Overview
	11.9.3. Products Offered
	11.9.4. Key Developments
	11.9.5. SWOT Analysis
	11.9.6. Key Strategies
	12. APPENDIX
	
	12.1. References
	12.2. Related Reports
	LIST OF TABLES
	
	TABLE 1 GLOBAL TISSUE DIAGNOSTICS MARKET, SYNOPSIS, 2019-2032
	TABLE 2 GLOBAL TISSUE DIAGNOSTICS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
	TABLE 3 GLOBAL TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 4 GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 5 GLOBAL TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 6 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 7 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 8 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 9 US: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 10 US: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 11 US: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 12 CANADA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 13 CANADA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 14 CANADA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 1 EUROPE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 2 EUROPE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 3 EUROPE: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 4 GERMANY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 5 GERMANY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 6 GERMANY: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 7 FRANCE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 8 FRANCE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 9 FRANCE: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 10 ITALY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 11 ITALY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 12 ITALY: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 13 SPAIN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 14 SPAIN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 15 SPAIN: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 16 UK: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 17 UK: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 18 UK: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 19 REST OF EUROPE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 20 REST OF EUROPE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 21 REST OF EUROPE: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 22 ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 23 ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 24 ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 25 JAPAN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 26 JAPAN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 27 JAPAN: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 28 CHINA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 29 CHINA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 30 CHINA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 31 INDIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 32 INDIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 33 INDIA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 34 AUSTRALIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 35 AUSTRALIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 36 AUSTRALIA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 37 SOUTH KOREA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 38 SOUTH KOREA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 39 SOUTH KOREA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 40 REST OF ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 41 REST OF ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 42 REST OF ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 43 REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 44 REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 45 REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 46 MIDDLE EAST: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 47 MIDDLE EAST: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 48 MIDDLE EAST: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 49 AFRICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 50 AFRICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 51 AFRICA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	TABLE 52 LATIN AMERICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
	TABLE 53 LATIN AMERICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
	TABLE 54 LATIN AMERICA: TISSUE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
	LIST OF FIGURES
	
	FIGURE 1 RESEARCH PROCESS
	FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL TISSUE DIAGNOSTICS MARKET
	FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL TISSUE DIAGNOSTICS MARKET
	FIGURE 4 GLOBAL TISSUE DIAGNOSTICS MARKET, SHARE (%), BY PRODUCT, 2023
	FIGURE 5 GLOBAL TISSUE DIAGNOSTICS MARKET, SHARE (%), BY TECHNOLOGY, 2023
	FIGURE 6 GLOBAL TISSUE DIAGNOSTICS MARKET, SHARE (%), BY APPLICATION, 2023
	FIGURE 7 GLOBAL TISSUE DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
	FIGURE 8 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
	FIGURE 9 EUROPE: TISSUE DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
	FIGURE 10 ASIA-PACIFIC: TISSUE DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
	FIGURE 11 REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
	FIGURE 12 GLOBAL TISSUE DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
	FIGURE 13 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 14 ABBOTT LABORATORIES: SWOT ANALYSIS
	FIGURE 15 BIOGENEX LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 16 BIOGENEX LABORATORIES: SWOT ANALYSIS
	FIGURE 17 AGILENT TECHNOLOGIES INC.: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 18 AGILENT TECHNOLOGIES INC.: SWOT ANALYSIS
	FIGURE 19 ILLUMINA INC.: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 20 ILLUMINA INC.: SWOT ANALYSIS
	FIGURE 21 MERCK KGA: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 22 MERCK KGA: SWOT ANALYSIS
	FIGURE 23 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 24 DANAHER CORPORATION: SWOT ANALYSIS
	FIGURE 25 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 26 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
	FIGURE 27 QIAGEN NV: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 28 QIAGEN NV: SWOT ANALYSIS
	FIGURE 29 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 30 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS